These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 14870952)
1. Correlation of hyperforin content of Hypericum perforatum (St John's Wort) extracts with their effects on alcohol drinking in C57BL/6J mice: a preliminary study. Wright CW; Gott M; Grayson B; Hanna M; Smith AG; Sunter A; Neill JC J Psychopharmacol; 2003 Dec; 17(4):403-8. PubMed ID: 14870952 [TBL] [Abstract][Full Text] [Related]
2. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content. Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879 [TBL] [Abstract][Full Text] [Related]
3. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of Hypericum perforatum on alcohol intake in rats. Perfumi M; Panocka I; Ciccocioppo R; Vitali D; Froldi R; Massi M Alcohol Alcohol; 2001; 36(3):199-206. PubMed ID: 11373255 [TBL] [Abstract][Full Text] [Related]
4. Hyperforin contributes to the hepatic CYP3A-inducing effect of Hypericum perforatum extract in the mouse. Cantoni L; Rozio M; Mangolini A; Hauri L; Caccia S Toxicol Sci; 2003 Sep; 75(1):25-30. PubMed ID: 12857935 [TBL] [Abstract][Full Text] [Related]
5. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG). Dimpfel W; Schober F; Mannel M Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945 [TBL] [Abstract][Full Text] [Related]
6. Reduction of ethanol intake by chronic treatment with Hypericum perforatum, alone or combined with naltrexone in rats. Perfumi M; Mattioli L; Cucculelli M; Massi M J Psychopharmacol; 2005 Sep; 19(5):448-54. PubMed ID: 16166181 [TBL] [Abstract][Full Text] [Related]
7. Enrichment of hyperforin from St. John's wort (Hypericum perforatum) by pilot-scale supercritical carbon dioxide extraction. Römpp H; Seger C; Kaiser CS; Haslinger E; Schmidt PC Eur J Pharm Sci; 2004 Mar; 21(4):443-51. PubMed ID: 14998574 [TBL] [Abstract][Full Text] [Related]
8. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect]. Vacek J; Klejdus B; Kubán V Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301 [TBL] [Abstract][Full Text] [Related]
9. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models. Butterweck V; Christoffel V; Nahrstedt A; Petereit F; Spengler B; Winterhoff H Life Sci; 2003 Jun; 73(5):627-39. PubMed ID: 12770617 [TBL] [Abstract][Full Text] [Related]
10. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line. Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377 [TBL] [Abstract][Full Text] [Related]
11. Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats. Butterweck V; Winterhoff H; Herkenham M Neuropsychopharmacology; 2003 Dec; 28(12):2160-8. PubMed ID: 12865894 [TBL] [Abstract][Full Text] [Related]
12. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study. Muruganandam AV; Bhattacharya SK; Ghosal S Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529 [TBL] [Abstract][Full Text] [Related]
13. NMDA receptor-antagonistic properties of hyperforin, a constituent of St. John's Wort. Kumar V; Mdzinarishvili A; Kiewert C; Abbruscato T; Bickel U; van der Schyf CJ; Klein J J Pharmacol Sci; 2006 Sep; 102(1):47-54. PubMed ID: 16936454 [TBL] [Abstract][Full Text] [Related]
14. Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells. Schempp CM; Winghofer B; Lüdtke R; Simon-Haarhaus B; Schöpf E; Simon JC Br J Dermatol; 2000 May; 142(5):979-84. PubMed ID: 10809859 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of hippocampal acetylcholine release by hyperforin, a constituent of St. John's Wort. Kiewert C; Buchholzer ML; Hartmann J; Chatterjee SS; Klein J Neurosci Lett; 2004 Jul; 364(3):195-8. PubMed ID: 15196674 [TBL] [Abstract][Full Text] [Related]
17. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line. Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577 [TBL] [Abstract][Full Text] [Related]
18. Attenuation of alcohol intake by extract of Hypericum perforatum (St. John's Wort) in two different strains of alcohol-preferring rats. Rezvani AH; Overstreet DH; Yang Y; Clark E Alcohol Alcohol; 1999; 34(5):699-705. PubMed ID: 10528812 [TBL] [Abstract][Full Text] [Related]
19. Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extracts. Cervo L; Rozio M; Ekalle-Soppo CB; Guiso G; Morazzoni P; Caccia S Psychopharmacology (Berl); 2002 Dec; 164(4):423-8. PubMed ID: 12457273 [TBL] [Abstract][Full Text] [Related]
20. Effect of eluent pH on the HPLC-UV analysis of hyperforin from St. John's Wort (Hypericum perforatum L.). Fourneron JD; Naït-Si Y Phytochem Anal; 2006; 17(2):71-7. PubMed ID: 16634282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]